Vincent Anzalone | VP, IR |
Dr. Christopher Anzalone | President and CEO |
Dr. Javier San Martin | Chief Medical Officer |
Dr. James Hamilton | SVP, Discovery and Translational Medicine |
Ken Myszkowski | CFO |
Tracie Oliver | Chief Commercial Officer |
Patrick O'Brien | Chief Operating Officer & General Counsel |
Maury Raycroft | Jefferies |
Luca Issi | RBC Capital Markets |
Ellie Merle | UBS |
Joel Beatty | Robert W. Baird |
Edward Tenthoff | Piper Sandler |
Patrick Trucchio | H.C. Wainwright |
Madhu Kumar | Goldman Sachs |
Mayank Mamtani | B. Riley Securities |
Keay Nakae | Chardan Capital Markets |
Mani Foroohar | SVB Securities |
Ladies and gentlemen, welcome to Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be opportunity to ask questions. I will now hand the conference over to Vincent Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince.